Management of new onset atrial fibrillation in previously well patients less than 60 years of age

EMA - Emergency Medicine Australasia

Volumn 17, Issue 1, 2005, Pages 4-10

  Taylor, David McD ^a   Aggarwal, Anuradha ^a   Carter, Michael ^a   Garewal, Devinder ^a   Hunt, David ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Atrial fibrillation; Cardioversion; Emergency department; Management; Medication

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; DIGOXIN; ENOXAPARIN; FLECAINIDE; MAGNESIUM SULFATE; METOPROLOL; SOTALOL; WARFARIN;

ADULT; ANTICOAGULATION; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SINUS RHYTHM; THYROTOXICOSIS;

EID: 13644265573     PISSN: 17426731     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2005.00687.x     Document Type: Review

References (20)

1. Danias PG, Caulfield TA, Weigner MJ, Silverman DI, Manning WJ. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J. Am. Coll. Cardiol. 1998; 31: 588-92.
2. Kopecky SL, Gersh BJ, McGoon MD et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N. Engl. J. Med. 1987; 317: 669-74.
3. Fuster V, Ryden LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur. Heart J. 2001; 22: 1852-923.
4. Williams E, Ansari M, Lip GY. Managing atrial fibrillation in the Accident and Emergency department. QJM 2001; 94: 609-14.
5. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. 2002; 347: 1825-33.
6. Brugada P. Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias. Eur. Heart J. 2000; 21: 1116.
7. Joseph AP, Ward MR. A prospective, randomised controlled trial comparing the efficacy and safety of Sotalol, Amiodarone and Digoxin for the reversion of new-onset atrial fibrillation. Ann. Emerg. Med. 2000; 36: 1-9.
8. Reisinger J, Gatterer E, Heinze G et al. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. Am. J. Cardiol. 1998; 81: 1450-4.
9. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann. Intern. Med. 1999; 131: 688-95.
10. Friedman HZ, Weber-Bornstein N, Deboe SF, Mancini GB. Cardiac care unit admission criteria for suspected acute myocardial infarction in new-onset atrial fibrillation. Am. J. Cardiol. 1987; 59: 866-9.
11. Zimetbaum PJ, Josephson ME, McDonald MJ et al. Incidence and predictors of myocardial infarction among patients with atrial fibrillation. J. Am. Coll. Cardiol. 2000; 36: 1223-7.
12. THE DIGITALIS IN ACUTE ATRIAL FIBRILLATION (DAAF) TRIAL GROUP. Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. Eur. Heart J. 1997; 18: 649-54.
13. Schreck DM, Rivera AR, Tricarico VJ. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin. Ann. Emerg. Med. 1997; 29: 135-40.
14. Farshi R, Kistner D, Sarma JS, Longmate JA, Singh BN. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J. Am. Coll. Cardiol. 1999; 33: 304-10.
15. Falk RH. Atrial fibrillation. N. Engl. J. Med. 2001; 344: 1067-78.
16. Chevalier P, Durand-Dubief A, Burri H et al. Amiodarone versus placebo and classic drugs for conversion of recent-onset atrial fibrillation: a meta-analysis. J. Am. Coll. Cardiol. 2003; 41: 255-62.
17. Prystowsky EN, Benson DW, Fuster V et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the subcommittee on electrocardiography and electrophysiology, American Heart Association. Circulation 1996; 93: 1262-77.
18. Weigner MJ, Caulfield TA, Danias PG, Silverman DI, Manning WJ. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann. Intern. Med. 1997; 126: 615-20.
19. Klein AL, Murray RD, Grimm RA. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J. Am. Coll. Cardiol. 2001; 37: 691-704.
20. Mead GE, Flapan AD, Elder AT. Electrical cardioversion for atrial fibrillation and flutter. Cochrane Database Syst. Rev. 2002; 1: CD002903.